Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue
- PMID: 10235597
- DOI: 10.1023/a:1026644110737
Decreased dopamine receptor expression and its second-messenger cAMP in malignant human colon tissue
Abstract
As an important enteric neurotransmitter, the role of dopamine as a mitotic inhibitor as well as a protective factor of epithelial cells of stomach and colon indicates its significance in malignant growth of gastrointestinal tract. Our previous results have shown significant alteration of dopamine receptors in human malignant stomach tissues. The present experiments, therefore, evaluate DA content, its receptor expression, and its second-messenger cAMP in human malignant colon tissues to evaluate its role. Results demonstrate a significant decrease of dopamine content, its receptor expression, and its second-messenger cAMP in malignant tissues of human colon. These results may provide insight into the role of dopamine as an enteric neurotransmitter on malignant growth of human colon and may also suggest a therapeutic approach targeting dopamine receptors and its signal transduction.
Similar articles
-
Alteration of dopamine D2 receptors in human malignant stomach tissue.Dig Dis Sci. 1997 Jun;42(6):1260-4. doi: 10.1023/a:1018862309440. Dig Dis Sci. 1997. PMID: 9201092
-
Dopamine receptors in a human colonic cancer cell line (HT29). Some receptor-related biological effects of dopamine.Int J Cancer. 1984 Nov 15;34(5):675-9. doi: 10.1002/ijc.2910340515. Int J Cancer. 1984. PMID: 6094366
-
The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.J Clin Invest. 1976 Mar;57(3):641-9. doi: 10.1172/JCI108320. J Clin Invest. 1976. PMID: 175089 Free PMC article.
-
The Akt-GSK-3 signaling cascade in the actions of dopamine.Trends Pharmacol Sci. 2007 Apr;28(4):166-72. doi: 10.1016/j.tips.2007.02.006. Epub 2007 Mar 8. Trends Pharmacol Sci. 2007. PMID: 17349698 Review.
-
Molecular biology of the invertebrate dopamine receptors.Arch Insect Biochem Physiol. 2005 Jul;59(3):103-17. doi: 10.1002/arch.20065. Arch Insect Biochem Physiol. 2005. PMID: 15986382 Review.
Cited by
-
Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists.Toxicol Res. 2024 Aug 7;40(4):533-540. doi: 10.1007/s43188-024-00259-8. eCollection 2024 Oct. Toxicol Res. 2024. PMID: 39345737 Review.
-
The Inhibitory Effect of Selected D2 Dopaminergic Receptor Agonists on VEGF-Dependent Neovascularization in Zebrafish Larvae: Potential New Therapy in Ophthalmic Diseases.Cells. 2022 Apr 2;11(7):1202. doi: 10.3390/cells11071202. Cells. 2022. PMID: 35406766 Free PMC article.
-
Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.J Neurooncol. 2014 Jan;116(2):237-49. doi: 10.1007/s11060-013-1313-1. Epub 2013 Nov 22. J Neurooncol. 2014. PMID: 24264533
-
DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.World J Surg. 2006 Sep;30(9):1672-9; discussion 1680-1. doi: 10.1007/s00268-006-0035-3. World J Surg. 2006. PMID: 16850143
-
Understanding the role of dopamine in cancer: past, present and future.Carcinogenesis. 2022 Jun 27;43(6):517-527. doi: 10.1093/carcin/bgac045. Carcinogenesis. 2022. PMID: 35616105 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials